SCHEMBL8767676

SCHEMBL8767676

N=C(N)N(CS(=O)(=O)O)C(=O)c1cccc(C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.47
GAA P10253 1/20 0.42
SRD5A2 P31213 1/20 0.41
KAT6A Q92794 1/20 0.41
TRPM8 Q7Z2W7 1/20 0.41
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
OPRM1 P35372 1/20 0.40
OPRL1 P41146 1/20 0.40
PTGS1 P23219 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27790261 0.71 CES2 (0.59) CES2GAASRD5A2KAT6AALDH1A1
SCHEMBL8503876 0.70 NPSR1 (0.55) CES2GAAKAT6AALDH1A1POLB
SCHEMBL8059721 0.70 CES2 (0.47) CES2SRD5A2KAT6ATRPM8ALDH1A1
SCHEMBL171684 0.70 CES2 (0.71) CES2SRD5A2POLBPTGS1NPSR1
SCHEMBL27621589 0.70 CES2 (0.71) CES2SRD5A2POLBPTGS1NPSR1
SCHEMBL524006 0.70 CES2 (0.60) CES2SRD5A2PTGS1
SCHEMBL25216553 0.69 CES2 (0.61) CES2GAASRD5A2ALDH1A1POLB
SCHEMBL3876454 0.69 CES2 (0.65) CES2GAASRD5A2ALDH1A1POLB
SCHEMBL20870672 0.69 CES2 (0.65) CES2GAASRD5A2ALDH1A1POLB
Hydrochloric Acid SCHEMBL1267321 0.68 CES2 (0.69) CES2SRD5A2POLBPTGS1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0612723-B1 Substituted benzoylguanidines, process for their preparation, their use as medicament, as inhibitor of the cellular Na+/H+ exchange or as diagnostic agent and medicament containing them HOECHST AG (DE) 1997-08-27 EP disclosed
EP-0612723-A1 Substituted benzoylguanidines, process for their preparation, their use as medicament, as inhibitor of the cellular Na+/H+ exchange or as diagnostic agent and medicament containing them HOECHST AKTIENGESELLSCHAFT (DE) 1994-08-31 EP disclosed